Inactive Instrument
Legion Metals Corp Stock Canadian Securities Exchange
Stocks
CA52490L1013
Pharmaceuticals
OTC Markets Traded| Market Cap | 6.8M 4.85M 4.21M 3.92M 3.6M 463M 6.9M 46.21M 18.14M 230M 18.2M 17.8M 772M | P/E 2024 |
-8x | P/E 2025 | -71.7x |
|---|---|---|---|---|---|
| Enterprise Value | 6.81M 4.85M 4.22M 3.93M 3.6M 463M 6.91M 46.27M 18.16M 231M 18.22M 17.82M 773M | EV / Sales 2024 |
1.05x | EV / Sales 2025 | 1.05x |
| Free-Float |
98.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -71.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Emma Andrews
CEO | Chief Executive Officer | - | 08/09/2023 |
Ted Kim
DFI | Director of Finance/CFO | - | - |
Sam Kassem
DFI | Director of Finance/CFO | - | 27/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Emma Andrews
BRD | Director/Board Member | - | 27/09/2023 |
Sherry Boodram
BRD | Director/Board Member | - | 16/10/2019 |
Fred Bonner
BRD | Director/Board Member | 64 | 01/03/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -71.43% | -.--% | - | - | 4.85M | ||
| +1.06% | -4.24% | +111.05% | -11.80% | 2.34B | ||
| +0.93% | +3.47% | +84.04% | +110.98% | 1.66B | ||
| +0.69% | -3.65% | -42.11% | +158.82% | 464M | ||
| -.--% | -.--% | +19.15% | +40.00% | 60.99M | ||
| Average | -13.75% | +0.31% | +43.04% | +74.50% | 1.13B | |
| Weighted average by Cap. | +0.88% | -1.22% | +84.22% | +51.45% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 12.48M 8.89M 7.73M 7.2M 6.61M 849M 12.67M 84.83M 33.29M 423M 33.4M 32.67M 1.42B | 11.26M 8.03M 6.98M 6.5M 5.96M 767M 11.44M 76.58M 30.06M 382M 30.16M 29.49M 1.28B |
| Net income | -1.44M -1.02M -890K -828K -760K -97.71M -1.46M -9.76M -3.83M -48.65M -3.84M -3.76M -163M | -163K -116K -101K -93.98K -86.29K -11.09M -165K -1.11M -435K -5.52M -436K -427K -18.51M |
| Net Debt | -53.84K -38.38K -33.36K -31.05K -28.51K -3.66M -54.68K -366K -144K -1.82M -144K -141K -6.12M | 7.72K 5.51K 4.79K 4.45K 4.09K 526K 7.84K 52.51K 20.61K 262K 20.68K 20.22K 877K |
Employees
-
Sector
Pharmaceuticals
















